Nijia Chang

机构：Chinese General Hospital College of Nursing and Liberal Arts

发表论文 5 篇 · 总被引 97 次 · h-index 3

代表论文

Silenced LINC01134 Enhances Oxaliplatin Sensitivity by Facilitating Ferroptosis Through GPX4 in Hepatocarcinoma (2022 · Frontiers in Oncology · 被引 48)
Lenvatinib plus sintilimab versus lenvatinib monotherapy as first-line treatment for advanced HBV-related hepatocellular carcinoma: A retrospective, real-world study (2022 · Heliyon · 被引 25)
A nomogram‑based immunoprofile predicts clinical outcomes for stage II and III human colorectal cancer (2021 · Molecular and Clinical Oncology · 被引 23)
Corrigendum to “Lenvatinib plus sintilimab versus lenvatinib monotherapy as first-line treatment for advanced HBV-related hepatocellular carcinoma: A retrospective, real-world study” [Heliyon 8 (6) (2022) e09538] (2022 · Heliyon · 被引 1)
Adaptive dosing of immunotherapy plus anti-angiogenic therapy in a nonagenarian with hepatocellular carcinoma: a case report with 10-year survival (2026 · Frontiers in Oncology)